Back to nephrectomy for patients with metastatic renal cancer
- 1 September 2001
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 358 (9286) , 948-949
- https://doi.org/10.1016/s0140-6736(01)06113-x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Placebo‐associated remissions in a multicentre, randomized, double‐blind trial of interferon γ‐1b for the treatment of metastatic renal cell carcinomaBJU International, 2000
- Interferon Gamma-1b Compared with Placebo in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 1998
- Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up.Journal of Clinical Oncology, 1993
- Immunotherapy for Advanced Renal Cell Cancer: The Role of Radical NephrectomyEuropean Urology, 1990
- Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trialsCancer, 1986
- The Role of Adjunctive Nephrectomy in Patients with Metastatic Renal Cell CarcinomaJournal of Urology, 1977
- Prognostic Significance of Renal Vein Invasion by HypernephromaJournal of Urology, 1968